Wyeth-Ayerst agrees $50 million Norplant settlement
This article was originally published in Clinica
Executive Summary
Wyeth-Ayerst Laboratories, the subsidiary of American Home Products (AHP) which sells the Norplant contraceptive implant in the US, has agreed a $50 million settlement relating to the claims by more than 36,000 women who had the device implanted and reported side effects.